跳至主要内容
临床试验/NCT01751659
NCT01751659已完成不适用

Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention

University of North Carolina, Chapel Hill1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
1
主要终点
Explore clinician attitudes and prescribing behaviors in MSM and heterosexually active adults

研究概览

简要总结

This is a three phase study designed to examine clinician behaviors with regard to recommending and prescribing pre-exposure prophylaxis (PrEP) as a primary Human Immunodeficiency Virus (HIV) prevention strategy, and to identify knowledge-related and attitudinal factors associated with these behaviors. Each phase consists of the following:

Phase 1: Semi-structured face-to-face or telephone interviews of ATN-affiliated clinicians. Approximately 10 clinicians will be interviewed.

Phase 2: Development of a new theory-based survey instrument and cognitive interview testing of this survey. Approximately five clinicians (of those who participated in Phase 1) will be interviewed.

Phase 3: Administration of the newly developed survey to ATN-affiliated clinicians. Approximately 60 clinicians will be interviewed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinicians (including physicians, nurse practitioners, and physician assistants) that EITHER: Provide primary HIV care for HIV-infected and primary care for HIV-uninfected adolescents; OR Provide primary HIV care to HIV-infected adolescents only;
  • Provides services to adolescents and young adults at ATN sites or one of their community partners;
  • Ability to understand spoken English; and
  • For Phase 2 only: prior participation in Phase 1.

排除标准

  • Intoxicated or under the influence of alcohol or other substances at the time of consent;
  • Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior) and in the opinion of the protocol chair would interfere with the ability to give true informed consent; and
  • For Phase 3 only: prior participation in Phase 1 or 2 of this study.

结局指标

主要结局

Explore clinician attitudes and prescribing behaviors in MSM and heterosexually active adults

时间窗: 2 years

Explore clinician attitudes and prescribing behaviors with regard to the use of PrEP in men who have sex with men (MSM) and heterosexually active adults as described in the current CDC guidelines, as well as in MSM and heterosexually active adolescents, who are not specifically covered by the guidelines

Identify factors associated with prescribing PrEP

时间窗: 2 years

Identify factors associated with prescribing PrEP, in a sample of clinicians who provide care to HIV-infected adolescents alone OR to HIV-infected and HIV-uninfected adolescents.

次要结局

  • Explore clinician attitudes toward the use of PrEP in potential target populations other than MSM and heterosexually active adults.(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验